PA8800101A1 - Producto de dispersion sólida que contiene un compuesto a base de n-aril urea - Google Patents
Producto de dispersion sólida que contiene un compuesto a base de n-aril ureaInfo
- Publication number
- PA8800101A1 PA8800101A1 PA20088800101A PA8800101A PA8800101A1 PA 8800101 A1 PA8800101 A1 PA 8800101A1 PA 20088800101 A PA20088800101 A PA 20088800101A PA 8800101 A PA8800101 A PA 8800101A PA 8800101 A1 PA8800101 A1 PA 8800101A1
- Authority
- PA
- Panama
- Prior art keywords
- solid dispersion
- aril
- urea
- based compound
- product containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99961807P | 2007-10-19 | 2007-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8800101A1 true PA8800101A1 (es) | 2009-05-15 |
Family
ID=40089463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20088800101A PA8800101A1 (es) | 2007-10-19 | 2008-10-17 | Producto de dispersion sólida que contiene un compuesto a base de n-aril urea |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP2197425A2 (fr) |
JP (1) | JP2011500649A (fr) |
KR (1) | KR20100087170A (fr) |
CN (1) | CN101827584A (fr) |
AU (1) | AU2008313622A1 (fr) |
BR (1) | BRPI0818340A2 (fr) |
CA (1) | CA2699301A1 (fr) |
CO (1) | CO6270206A2 (fr) |
CR (1) | CR11442A (fr) |
DO (1) | DOP2010000117A (fr) |
EC (1) | ECSP10010183A (fr) |
GT (1) | GT201000102A (fr) |
MX (1) | MX2010004291A (fr) |
PA (1) | PA8800101A1 (fr) |
RU (1) | RU2010119929A (fr) |
UA (1) | UA100865C2 (fr) |
WO (1) | WO2009050291A2 (fr) |
ZA (1) | ZA201002095B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009100176A2 (fr) * | 2008-02-07 | 2009-08-13 | Abbott Laboratories | Forme pharmaceutique pour administration orale d’un inhibiteur de tyrosine kinase |
AR077975A1 (es) | 2009-08-28 | 2011-10-05 | Irm Llc | Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina |
AU2011264993B2 (en) * | 2010-06-09 | 2014-02-06 | Abbvie Bahamas Ltd. | Solid dispersions containing kinase inhibitors |
CN108542906A (zh) | 2011-11-11 | 2018-09-18 | 诺华股份有限公司 | 治疗增生性疾病的方法 |
JP6216325B2 (ja) * | 2011-11-23 | 2017-10-18 | ノバルティス アーゲー | 医薬製剤 |
WO2014003678A1 (fr) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Compositions pharmaceutiques comprenant de l'ambrisentan et des particules de dispersion solide contenant du tadalafil |
WO2014003677A1 (fr) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Compositions pharmaceutiques comprenant des particules de dispersion solide contenant du tadalafil |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101346128B (zh) * | 2005-10-25 | 2013-10-02 | 雅培制药有限公司 | 包含低水溶解度药物的配方及其使用方法 |
WO2007066189A2 (fr) * | 2005-12-09 | 2007-06-14 | Pfizer Products Inc. | Sels, promedicaments et formulations de 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-uree |
CA2667720A1 (fr) * | 2006-11-09 | 2008-05-15 | Abbott Gmbh & Co. Kg. | Forme de dosage pharmaceutique pour l'administration orale d'un inhibiteur de la tyrosine kinase |
-
2008
- 2008-10-17 CN CN200880112150A patent/CN101827584A/zh active Pending
- 2008-10-17 WO PCT/EP2008/064076 patent/WO2009050291A2/fr active Application Filing
- 2008-10-17 RU RU2010119929/15A patent/RU2010119929A/ru not_active Application Discontinuation
- 2008-10-17 MX MX2010004291A patent/MX2010004291A/es not_active Application Discontinuation
- 2008-10-17 BR BRPI0818340 patent/BRPI0818340A2/pt not_active IP Right Cessation
- 2008-10-17 CA CA2699301A patent/CA2699301A1/fr not_active Abandoned
- 2008-10-17 UA UAA201006029A patent/UA100865C2/ru unknown
- 2008-10-17 EP EP08839333A patent/EP2197425A2/fr not_active Withdrawn
- 2008-10-17 KR KR1020107010979A patent/KR20100087170A/ko not_active Application Discontinuation
- 2008-10-17 JP JP2010529408A patent/JP2011500649A/ja active Pending
- 2008-10-17 PA PA20088800101A patent/PA8800101A1/es unknown
- 2008-10-17 AU AU2008313622A patent/AU2008313622A1/en not_active Abandoned
-
2010
- 2010-03-24 ZA ZA2010/02095A patent/ZA201002095B/en unknown
- 2010-04-16 DO DO2010000117A patent/DOP2010000117A/es unknown
- 2010-04-16 GT GT201000102A patent/GT201000102A/es unknown
- 2010-04-27 CO CO10049271A patent/CO6270206A2/es not_active Application Discontinuation
- 2010-05-17 EC EC2010010183A patent/ECSP10010183A/es unknown
- 2010-05-19 CR CR11442A patent/CR11442A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UA100865C2 (ru) | 2013-02-11 |
CA2699301A1 (fr) | 2009-04-23 |
ZA201002095B (en) | 2011-11-30 |
CO6270206A2 (es) | 2011-04-20 |
DOP2010000117A (es) | 2010-05-15 |
KR20100087170A (ko) | 2010-08-03 |
MX2010004291A (es) | 2010-08-02 |
CN101827584A (zh) | 2010-09-08 |
AU2008313622A1 (en) | 2009-04-23 |
WO2009050291A3 (fr) | 2010-04-08 |
JP2011500649A (ja) | 2011-01-06 |
WO2009050291A2 (fr) | 2009-04-23 |
GT201000102A (es) | 2012-03-12 |
EP2197425A2 (fr) | 2010-06-23 |
BRPI0818340A2 (pt) | 2015-04-22 |
ECSP10010183A (es) | 2010-06-29 |
CR11442A (es) | 2010-09-06 |
RU2010119929A (ru) | 2011-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT201000095A (es) | Producto de dispersión sólida que contiene un compuesto a base de n-aril urea | |
PA8800101A1 (es) | Producto de dispersion sólida que contiene un compuesto a base de n-aril urea | |
AR051969A1 (es) | Metodos y composiciones que usan compuestos inmunomoduladores para el tratamiento y el manejo de lesiones del sistema nervioso central | |
UY29701A1 (es) | Formulaciones líquidas para la administración controlada de derivados de bencisoxazol | |
CL2009001560A1 (es) | Composición nutricional para bebes que comprende una mezcla de oligosacáridos compuesta de oligosacáridos n-acetilados, galactooligosácaridos y oligosacáridos sialilados; y su uso. | |
AR083016A1 (es) | Formulaciones liquidas para la agricultura con una mejor estabilidad | |
AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
HN2010001059A (es) | Nuevo titulo modificado: compuestos derivados de pirimidina, un proceso para la preparacion de los mismos, una composicion farmaceutica que los comprenden y combinaciones de dichos compuestos con otros agentes. | |
UY30759A1 (es) | Compuestos quimicos | |
CO6251200A2 (es) | Metodo para modular la tasa de liberacion de ingredientes activos microencapsulados usado paa la proteccion de cultivos | |
CY1110037T1 (el) | Σκευασματα για βενζιμιδαζολυλ πυριδυλ αιθερες | |
BRPI0719277A2 (pt) | Formulação fitossanitária concentrada, utilização da formulação e composição solvente compreendendo uma mistura de solventes | |
CL2007002754A1 (es) | Composicion emulsionante de agroquimicos activos, tensoactivos, solventes aromaticos, diacetato de propilenglicol, 1,3-dimetil-2-imidazolidinona y auxiliares de formulacion; solvente para compuestos agroquimicos; dilucion que comprende la composicion | |
PA8577201A1 (es) | 3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b | |
GB201308923D0 (en) | Semiconductor blend | |
DOP2010000374A (es) | Derivados heterociclicos de la urea y sus metodos de empleo | |
UY28366A1 (es) | Compuestos químicos | |
CL2007001981A1 (es) | Composicion que comprende al menos un principio activo agroquimico del grupo de los piretroides, al menos un tensioactivo, y al menos un disolvente no miscible en agua; procedimiento para la lucha contra las plagas animales; y su uso. | |
CL2011001207A1 (es) | Extruidos que contienen al menos una sustancia farmacéuticamente activa en forma de agujas, tal que la relación entre el tamaño de partículas de la sustancia farmacéuticamente activa con forma de agujas y el diámetro de la cadena es de al menos 1:20; composición farmacéutica; y su uso para preparar medicamentos. | |
CL2008001650A1 (es) | Procedimiento de preparacion de una disolucion de docetaxel en polisorbato 80 que consiste en disolver el docetaxel en un disolvente organico que tiene un punto de ebullicion comprendido entre 40-153 grados celsius, con la excepcion de etanol, se mezcla la disolucion con polisorbato 80, se evapora el disolvente bajo presion reducida. | |
CL2009001370A1 (es) | Formas cristalinas de (r,s)-, (r)- y (s)-dopc; proceso de preparacion; composicion farmaceutica; y su uso para preparar medicamentos. | |
TH104743B (th) | ผลิตภัณฑ์แพร่กระจายแข็งที่มีสารประกอบ n-อะริล ยูเรีย | |
CO6270249A2 (es) | Fibra, pelicula o espuma que comprende un plastificador y un gel ligado a arcilla cargado y metodos para su produccion | |
AR046666A1 (es) | Composiciones farmaceuticas estabilizadas con carbonato de calcio | |
TH161414B (th) | สูตรผสมโอปิออยด์ |